Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

darmerica, llc - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) -

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

sichuan qingmu pharmaceutical co., ltd. - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) -

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - indications: previcox (firocoxib) chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs. contraindications: dogs with known hypersensitivity to firocoxib should not receive previcox.

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - firocoxib - unknown - firocoxib anilinopyrimidine active 0.0 - active constituent

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - firocoxib - unknown - firocoxib anilinopyrimidine active 0.0 - active constituent

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - equioxx tablets are administered once daily for up to 14 days for the control of pain and inflammation associated with osteoarthritis in horses. horses with a hypersensitivity to firocoxib should not receive equioxx® tablets.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

norbrook laboratories limited - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - firox (firocoxib) chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs. dogs with known hypersensitivity to firocoxib should not receive firox.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

aspen veterinary resources - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - flexira (firocoxib) chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs. dogs with known hypersensitivity to firocoxib should not receive flexira.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

mwi/vetone - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - osticoxib (firocoxib) chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs. dogs with known hypersensitivity to firocoxib should not receive osticoxib.

Европска Унија - Енглески - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - reduction of neonatal enterotoxicosis of piglets, caused by e. coli strains, expressing the adhesins f4ab, f4ac, f4ad, f5, f6 and f41, during the first days of life.